Open Access. Powered by Scholars. Published by Universities.®

Business Commons

Open Access. Powered by Scholars. Published by Universities.®

Entrepreneurial and Small Business Operations

PDF

Biotechnology

Articles 1 - 5 of 5

Full-Text Articles in Business

Outsourcing The Packaging Function, Rihaz Z. Chughatta Apr 2007

Outsourcing The Packaging Function, Rihaz Z. Chughatta

Rihaz Z Chughatta

If you are currently working in the packaging department of a major corporation in the pharmaceutical, food or consumer products industry, you have probably been exposed to some form of outsourcing, which is a global trend that has emerged over the past decade, and continues to evolve, within the packaging field.


A Comparative Analysis Of The Performance Of Emerging Versus Nonemerging Industry Initial Public Offerings, Todd A. Finkle, Reinhold Lamb Dec 2001

A Comparative Analysis Of The Performance Of Emerging Versus Nonemerging Industry Initial Public Offerings, Todd A. Finkle, Reinhold Lamb

Todd A Finkle

This study fills a gap in previous research by investigating differences between the short and long run aftermarket performance in a sample of emerging versus non-emerging industries. Utilizing the entire population of biotechnology, semiconductor, and Internet IPOs from 1993-1996 as a representative sample of emerging industries, this study found that emerging firms were significantly underpriced compared to a set of non-emerging IPOs.


The Performance Of Initial Public Offerings In The Biotechnology Industry, Todd A. Finkle, Dan French Dec 1997

The Performance Of Initial Public Offerings In The Biotechnology Industry, Todd A. Finkle, Dan French

Todd A Finkle

This study examines the underpricing and aftermarket performance of the emerging industry of biotechnology. Findings indicate that the average first day return for the biotech firms was 1.8 and 1.6 percent. Furthermore, the biotech firms significantly underperformed the NASDAQ (-30.7%) and NYSE (-16.5%) over a two-year period after going public.


An Examination Of Initial Public Offerings In The “High Flying” Internet Industry, Todd A. Finkle, Dan French Dec 1997

An Examination Of Initial Public Offerings In The “High Flying” Internet Industry, Todd A. Finkle, Dan French

Todd A Finkle

This study examines the underpricing and aftermarket performance of the emerging industry of biotechnology. Findings indicate that the average first day return for the biotech firms was 1.8 and 1.6 percent. Furthermore, the biotech firms significantly underperformed the NASDAQ (-30.7%) and NYSE (-16.5%) over a two-year period after going public.


The Relationship Between Boards Of Directors And Initial Public Offerings In The Biotechnology Industry, Todd A. Finkle Dec 1997

The Relationship Between Boards Of Directors And Initial Public Offerings In The Biotechnology Industry, Todd A. Finkle

Todd A Finkle

Utilizing the entire population of public biotechnology firms from 1980-1994, three models were tested to determine if a relationship exists between the size and composition of the board of directors with performance. Results indicate significant positive relationships between director expertise and the size of a firm’s initial public offering. Going public during hot markets and larger firms were also related to larger initial public offerings. These findings will benefit practitioners in the formation of boards within the biotechnology industry. Managers of firms within the biotechnology industry who are contemplating a public offering will be able to proactively address the composition …